by University of California, San Francisco Credit: CC0 Public DomainHeadache, chills, tiredness may be evidence of a supercharged defense, according to UCSF-led study. Fewer than 1 in 4 people in the United States have received last year’s updated COVID-19 vaccine, despite a death toll of more than 23,000 Americans this year. One of the most...
Tag: <span>COVID shot</span>
Post
Older US adults should get another COVID-19 shot, health officials recommend
by Mike Stobbe Comirnaty, a new Pfizer/BioNTech vaccination booster for COVID-19, is displayed at a pharmacy in Orlando, Fla., on Friday, Sept. 15, 2023. Older U.S. adults should roll up their sleeves for another COVID-19 shot, even if they received a booster in the fall, an influential government advisory panel said Wednesday, Feb. 28, 2024....
Post
Study: Experimental COVID shot made via egg-based technology elicits higher antibody proportion than mRNA vax
by Delthia Ricks, Medical Xpress Neutralizing activity of vaccinee and convalescent serum samples against wild-type SARS-CoV-2 and Delta and Beta variants.Neutralization was measured against (A) wild-type SARS-CoV-2 strain USA-WA01/2020, (B) a Delta (B.1.617.2) isolate, and (C) a Beta (B.1.351) isolate in a microneutralization assay with authentic SARS-CoV-2. For vaccine groups, n = 35, nBNT162b2 = 20, and nHCS = 18. The exception is n3 μg = 34...
Post
Moderna says updated COVID shot boosts omicron protection
by Lauran Neergaard In this Dec. 15, 2020, file photo, a sign for Moderna, Inc. hangs on its headquarters in Cambridge, Mass. Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday, June 8, 2022. COVID-19 vaccine makers are studying updated boosters that...
Post
Study: Chinese COVID shot may offer elderly poor protection
by Huizhong Wu and Justin Spike In this April 1, 2021, file photo, vials of COVID-19 vaccines produced by Chinese Sinopharm are seen in the office of general practitioner Gyorgy Teleki in Taplanszentkereszt, Hungary. A new study suggests that a Sinopharm vaccine offers poor protection from COVID-19 among the elderly, raising questions for dozens of...